Skip to content

Development of an assessment instrument to evaluate the ability to manage various dosage forms

Development of an assessment instrument to evaluate the ability to manage various dosage forms - ASSMED

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025788
Enrollment
100
Registered
2021-09-07
Start date
2021-09-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POLYPHARMACY

Interventions

Group 1: Study participants will pass through a complex assessment battery consisting of an interview, geriatric assessments, and newly developed assessments. In the newly developed assessments, parti

Sponsors

Universitätsklinikum Düsseldorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: 70 years or older, at least 5 drugs used continuously, treatment at Düsseldorf University Hospital, written consent of the patient

Exclusion criteria

Exclusion criteria: legal care, inability to communicate due to language barriers or hearing loss, repeated inclusion due to recurrent treatments, visual impairment, cognitive impairment (minimum score of 4 on the Six Items Screening), inability to write, no written consent of the patient, instable clinical situation, patients with palliative care

Design outcomes

Primary

MeasureTime frame
The results of the tests will be used to develop an everyday test battery, which will quickly provide an impression whether a patient is able to manage his medication himself or not.

Secondary

MeasureTime frame
the following questions should be answered: How much is the need for improvement? How many patients can adequately use their medication independently? How much is the need for support? Are there clusters of patients in terms of independence and need for support? Do parameters of the geriatric assessment allow a prediction regarding medication management? Do the newly created tests allow a prediction? How good is a patient's adherence and what does it correlate with?

Countries

Germany

Contacts

Public ContactHelmut Frohnhofen

Universitätsklinikum Düsseldorf

h.frohnhofen@med.uni-duesseldorf.de0211-8118314

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026